This must-attend one day interactive forum will bring together 150 CEOs and senior executives to discuss the critical issues that affect product commercialization and the common challenges faced by med-tech companies today. Hear from some of the top industry experts and government officials who will address investment options, FDA reforms, reimbursement strategies and much more.